Safety, not only efficacy still to be proven for controversial new MS treatment
- PMID: 21856565
- DOI: 10.1017/s0317167100118578
Safety, not only efficacy still to be proven for controversial new MS treatment
Comment on
-
Complications in MS patients after CCSVI procedures abroad (Calgary, AB).Can J Neurol Sci. 2011 Sep;38(5):741-6. doi: 10.1017/s0317167100054123. Can J Neurol Sci. 2011. PMID: 21856578
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
